Evidence Hub

Effects of perilla oil on platelet and inflammatory responses in healthy smokers: a randomized, double-blind, placebo-controlled, parallel trial

Lee S, Kim KJ, Park MJ, Park SY, Kim YJ, Yoo H, Kim JY

Food & function, 2026

Abstract

α-Linolenic acid (ALA), a plant-derived omega-3 fatty acid, has been reported to exert anti-atherosclerotic and anti-inflammatory effects. Perilla oil (PO), a rich dietary source of ALA, has yet to be comprehensively evaluated for its effects on blood circulation. This randomized, double-blind, placebo-controlled trial assessed the effects of 8-week PO supplementation (4.8 g per day) on blood coagulation, and inflammatory response in healthy smokers. The PO intake significantly prolonged collagen-induced ADP-closure time (P = 0.045) and reduced mRNA expression of tumor necrosis factor-α (P = 0.027) and T-box transcription factor 21 (P = 0.022). In addition, PO supplementation for 8 weeks increased the proportion of ALA in plasma (P = 0.003) and red blood cells (P = 0.013), as well as eicosapentaenoic acid in plasma (P = 0.019). These findings suggest that PO supplementation increases blood omega-3 levels and modulates blood coagulation and inflammatory responses, potentially supporting blood flow.

How strong is the evidence?

Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free